BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26053157)

  • 1. Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
    Tilley C; Deep G; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):688-97. PubMed ID: 26053157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
    Tilley C; Deep G; Agarwal C; Wempe MF; Biedermann D; Valentová K; Kren V; Agarwal R
    Mol Carcinog; 2016 Jan; 55(1):3-14. PubMed ID: 25492239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/- mice.
    Paudel S; Raina K; Tiku VR; Maurya A; Orlicky DJ; You Z; Rigby CM; Deep G; Kant R; Raina B; Agarwal C; Agarwal R
    Carcinogenesis; 2022 Jun; 43(6):557-570. PubMed ID: 35184170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
    Albert B; Hahn H
    Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics.
    Bisceglia M; Panniello G; Galliani CA; Centola M; D'Errico MM; Minenna E; Tucci FA; Ben-Dor DJ
    Adv Anat Pathol; 2020 Sep; 27(5):331-353. PubMed ID: 32618586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
    Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
    Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
    Rigby C; Deep G; Jain A; Orlicky DJ; Agarwal C; Agarwal R
    Mol Carcinog; 2019 Jul; 58(7):1260-1271. PubMed ID: 30912211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog signalling in skin development and cancer.
    Athar M; Tang X; Lee JL; Kopelovich L; Kim AL
    Exp Dermatol; 2006 Sep; 15(9):667-77. PubMed ID: 16881963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the scalpel: targeting hedgehog in skin cancer prevention.
    Rudin CM
    Cancer Prev Res (Phila); 2010 Jan; 3(1):1-3. PubMed ID: 20051365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
    PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible chemopreventive role for photodynamic therapy in Gorlin syndrome: a report of basal cell carcinoma reduction and review of literature.
    Wolfe CM; Green WH; Cognetta AB; Hatfield HK
    Australas J Dermatol; 2013 Feb; 54(1):64-8. PubMed ID: 22780558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Molecular Genetics of Basal Cell Carcinoma.
    Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel investigational drugs for basal cell carcinoma.
    So PL; Tang JY; Epstein EH
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1099-112. PubMed ID: 20662553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 gene expression in basal cell carcinoma.
    Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
    Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
    Caro I; Low JA
    Clin Cancer Res; 2010 Jul; 16(13):3335-9. PubMed ID: 20439455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
    Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
    Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.